T. Rowe Price Associates’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,411	Closed	-$346K	–	2591
2018 Q3	$346K	Buy	1,411 +414	+42%	+$102K	﹤0.01%	2290
2018 Q2	$223K	Hold	997	–	–	﹤0.01%	2416
2018 Q1	$244K	Sell	997 -416	-29%	-$102K	﹤0.01%	2348
2017 Q4	$435K	Buy	+1,413	New	+$435K	﹤0.01%	2123